|
Volumn 345, Issue 12, 2001, Pages 912-914
|
Withholding proven treatment in clinical research
a a
a
HEALTH CANADA
(Canada)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
BLOOD PRESSURE REGULATION;
DIABETIC NEPHROPATHY;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
EDITORIAL;
HUMAN;
MEDICAL ETHICS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PATIENT MONITORING;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
CLINICAL APPROACH/SOURCE;
CONTROLLED CLINICAL TRIALS;
ETHICS, MEDICAL;
HUMANS;
PLACEBOS;
WITHHOLDING TREATMENT;
|
EID: 0035922432
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200109203451210 Document Type: Editorial |
Times cited : (41)
|
References (16)
|